advertisement
Abstract #46405 Published in IGR 13-3
Neurotrophic factor delivery as a protective treatment for glaucoma
Johnson TV; Bull ND; Martin KRExperimental Eye Research 2011; 93: 196-203
Glaucoma is a progressive optic neuropathy and a major cause of visual impairment worldwide. Neuroprotective therapies for glaucoma aim to ameliorate retinal ganglion cell degeneration through direct or indirect action on these neurons. Neurotrophic factor (NTF) delivery is a key target for the development of potential neuroprotective glaucoma treatments.This article will critically summarize the evidence that NTF deprivation and/or dysfunction plays a role in the pathogenesis of glaucoma. Experimental support for the neuroprotective potential of NTF supplementation in animal models of glaucoma will be reviewed, in particular for brain-derived neurotrophic factor, ciliary neurotrophic factor, and glial cell line-derived neurotrophic factor. Finally, the challenges of clinical translation will be considered with an emphasis on the most promising NTF delivery strategies including slow-release drug delivery, gene therapy, and cell transplantation.
Centre for Brain Repair, Department of Ophthalmology, University of Cambridge, Forvie Site, Robinson Way, Cambridge, UK.
Classification:
11.8 Neuroprotection (Part of: 11 Medical treatment)
